Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Arcturus Therapeutics (ARCT – Research Report) and Humacyte (HUMA – Research Report). Arcturus Therapeutics (ARCT) In a report released today, Ed Arce from H.C. Wainwright maintained a Hold rating on Arcturus Therapeutics, with a price target of $19.00. The company's shares closed last Thursday at $19.99. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-arcturus-therapeutics-arct-and-humacyte-huma?utm_source=advfn.com&utm_medium=referral